Literature DB >> 17092774

Blood purification for hypercytokinemia.

Taka-aki Nakada1, Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, Ken-ichi Matsuda.   

Abstract

Blood purification has been steadily improved in the field of critical care, supported by advances in related biomedical technologies as well as efforts to develop better operating procedures. As it has become clear that hypercytokinemia plays a key role in the pathophysiology of critical pathological conditions, use of various blood purification techniques to control hypercytokinemia has been investigated. Answers to questions concerning the optimal cytokine-removing device (dialyzer/hemofilter/adsorber) as well as operating procedures and conditions of such devices in particular clinical conditions have been obtained in the course of such investigations. The recent success in real-time monitoring of cytokine levels in clinical practice to assess the extent of cytokine network activation may improve the precision and efficacy of blood purification in the treatment of hypercytokinemia. In addition, the recently documented effects of genetic factors on hypercytokinemia suggest that the introduction of tailor-made medicine considering the differences in genetic background among individual patients may improve the efficacy of blood purification as a countermeasure to hypercytokinemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092774     DOI: 10.1016/j.transci.2006.06.004

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  7 in total

Review 1.  Changes in acute blood purification therapy in critical care: republication of the article published in the Japanese Journal of Artificial Organs.

Authors:  Taka-Aki Nakada; Shigeto Oda; Ryuzo Abe; Noriyuki Hattori
Journal:  J Artif Organs       Date:  2019-06-24       Impact factor: 1.731

2.  Proteome analysis of hemofilter adsorbates to identify novel substances of sepsis: a pilot study.

Authors:  Tomoaki Hashida; Taka-Aki Nakada; Mamoru Satoh; Keisuke Tomita; Rui Kawaguchi; Fumio Nomura; Shigeto Oda
Journal:  J Artif Organs       Date:  2016-11-17       Impact factor: 1.731

3.  Clinical study of blood purification therapy in critical care in Japan: results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013.

Authors:  Toshiaki Arimura; Masanori Abe; Hidetoshi Shiga; Hiroshi Katayama; Kazo Kaizu; Shigeto Oda
Journal:  J Artif Organs       Date:  2017-06-09       Impact factor: 1.731

4.  Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock.

Authors:  Taka-Aki Nakada; Shigeto Oda; Ken-Ichi Matsuda; Tomohito Sadahiro; Masataka Nakamura; Ryuzo Abe; Hiroyuki Hirasawa
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

5.  Usefulness of the endotoxin activity assay to evaluate the degree of lung injury.

Authors:  Yuichiro Sakamoto; Satoshi Inoue; Takashi Iwamura; Tomoko Yamashita; Atsushi Nakashima; Hiroyuki Koami; Toru Miike; Mayuko Yahata; Hisashi Imahase; Akiko Goto; Showgo Narumi; Miho Ohta; Chris-Kosuke Yamada
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

6.  Serum levels of interleukin-6 may predict organ dysfunction earlier than SOFA score.

Authors:  Takashi Shimazui; Yosuke Matsumura; Taka-Aki Nakada; Shigeto Oda
Journal:  Acute Med Surg       Date:  2017-03-06

7.  A Larger Membrane Area Increases Cytokine Removal in Polymethyl Methacrylate Hemofilters.

Authors:  Tomoyuki Nakamura; Kazuhiro Moriyama; Naohide Kuriyama; Yoshitaka Hara; Satoshi Komatsu; Takahiro Kawaji; Yu Kato; Takuma Ishihara; Ayumi Shintani; Osamu Nishida
Journal:  Membranes (Basel)       Date:  2022-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.